BIOMAT Database Logo BIOMAT Database Logo

[Summary: Secondary prophylaxis following myocardial re-infarct. Anticoagulants or thrombocyte function inhibitors?]. 1980

K Breddin, and E A Loeliger

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic

Related Publications

K Breddin, and E A Loeliger
[Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].
January 1985, Zeitschrift fur arztliche Fortbildung,
K Breddin, and E A Loeliger
[Pro and con: Anticoagulation or thrombocyte function inhibitors in the prophylaxis of myocardial infarct? Arguments in favor of thrombocyte function inhibitors].
July 1980, Der Internist,
K Breddin, and E A Loeliger
[Summary: Aggregation inhibitors in the prophylaxis of myocardial infarct].
July 1980, Der Internist,
K Breddin, and E A Loeliger
[Pro and con: Anticoagulation or thrombocyte function inhibitors in the prophylaxis of myocardial infarct? Arguments in favor of anticoagulation].
July 1980, Der Internist,
K Breddin, and E A Loeliger
[Letter: Anticoagulants following myocardial infarct].
August 1975, Deutsche medizinische Wochenschrift (1946),
K Breddin, and E A Loeliger
[Stroke prevention with thrombocyte function inhibitors and anticoagulants].
April 2000, Der Internist,
K Breddin, and E A Loeliger
[Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct].
October 1998, Recenti progressi in medicina,
K Breddin, and E A Loeliger
[Thrombocyte function and the repair of myocardial infarct].
January 1989, Vrachebnoe delo,
K Breddin, and E A Loeliger
[Problems in the treatment of myocardial infarct using anticoagulants or aggregation inhibitors].
August 1972, Das Deutsche Gesundheitswesen,
K Breddin, and E A Loeliger
[Anticoagulants and thrombocyte aggregation inhibitors in the treatment of heart infarct. A survey].
January 1983, Fortschritte der Medizin,
Copied contents to your clipboard!